Cardiac Prosthetic Devices Market Size

Global Cardiac Prosthetic Devices Market size was valued at USD 6.93 billion in 2023 and is poised to grow from USD 7.47 billion in 2024 to USD 13.62 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The major force behind the global market for cardiac prosthetic devices is the fast-expanding population of old age. With increasing age, the cardiovascular system undergoes structural and functional alterations rendering the individual vulnerable to the development of diseases such as aortic stenosis, arrhythmias, and heart failure. This vulnerability results in a greater prevalence of degenerative heart diseases which are frequently treated with surgical or percutaneous procedures involving prosthetic valves or pacemakers. Consequently, the need for sophisticated cardiac prosthetic devices has increased to address the healthcare needs of this growing population directly, driving market growth through the rising level of hospital admissions and medical procedures.

Technological innovation is the key driver driving the global cardiac prosthetic devices sector. Breakthroughs like minimally invasive transcatheter aortic valve replacement (TAVR), biocompatible materials, and 3D-printed personalized heart valves have greatly improved the safety, longevity, and effectiveness of cardiac prosthetics. These innovations minimize risks during surgery, shorten recovery periods, and enhance long-term results, making such devices more desirable to patients and healthcare professionals alike. Moreover, intelligent prosthetics with sensors for real-time monitoring facilitate improved post-operative care. As a result, ongoing technological advancements boost device uptake, expand treatment options, and maintain market growth by addressing changing patient and clinician needs.

In What Ways has AI Shortened the Time for Designing Personalized Heart Valve Prosthetics?

Artificial intelligence (AI) is playing a strong role in revolutionizing the global cardiac prosthetic devices market through personalized augmentation, diagnosis, and surgical planning. Deep learning models driven by AI are able to interpret patient-specific imaging data in order to create patient-specific fit prosthetic heart valves that are more durable and less prone to complications. For example, scientists at Iowa State University used AI to quickly create personalized valve geometries using MRI or CT scans, reducing design time from days to hours. Also, AI algorithms enhance diagnostic precision by reading ECGs and imaging for valvular disease early, enabling timely interventions. These advances result in improved patient outcomes, higher prosthetic device adoption, and propel market expansion.

In March 2025, MIT startup Spheric Bio unveiled AI-driven personalized heart implants that mold exactly to a patient's individual heart anatomy. The growing implants, which close the left atrial appendage, a source of clots in atrial fibrillation patients, with perfect closure, will prevent strokes.